Clinical predictors of 5-year survival in patients with EGFR-mutant metastatic NSCLC treated with EGFR-TKIs.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jessica Jiyeong Lin, Stephanie Cardarella, Christine A. Lydon, Suzanne Eleanor Dahlberg, David Michael Jackman, Pasi A. Janne, Bruce E. Johnson
Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2605370005
